Nicole Lambert - 31 Oct 2023 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Reporting relationship: Chief Operating Officer
Issuer ticker: MYGN
Reported as of: 31 Oct 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Nov 2023, 16:13:01 UTC
Prior SEC filing: 10 Oct 2023
Next SEC filing: 07 Jun 2024
Source filing: View source filing
Reporting owner signature: By: Justin Hunter For: Nicole Lambert

Key filing fact

Nicole Lambert filed Form 4 for MYRIAD GENETICS INC (MYGN) on 01 Nov 2023.

Key facts

This page summarizes Nicole Lambert's Form 4 filing for MYRIAD GENETICS INC (MYGN).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 01 Nov 2023, 16:13.

Change

Previous filing in this sequence was filed on 10 Oct 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 223,993
Date: 31 Oct 2023
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Nicole Lambert is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

SEC remarks

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief Operating Officer, effective October 31, 2023, and therefore is no longer subject to Section 16 reporting.